medigraphic.com
Instituto Nacional de Salud Pública

2013, Number 6

<< Back Next >>

salud publica mex 2013; 55 (6)

Burden of disease, injuries, risk factors and challenges for the health system in Mexico

Lozano R, Gómez-Dantés H, Garrido-Latorre F, Jiménez-Corona A, Campuzano-Rincón JC, Franco-Marina F, Medina-Mora ME, Borges G, Naghavi M, Wang H, Vos T, Lopez AD, Murray CJL

Language: Spanish
References: 101
Page: 580-594
PDF size: 236.19 Kb.


ABSTRACT

Objective. To present the results of the burden of disease, injuries and risk factors in Mexico from 1990 to 2010 for the principal illnesses, injuries and risk factors by sex. Materials and methods. A secondary analysis of the study results published by the Global Burden of Disease 2010 for Mexico performed by IHME. Results. In 2010, Mexico lost 26.2 million of Disability adjusted live years (DALYs), 56 % were in male and 44 % in women. The main causes of DALYs in men are violence, ischemic heart disease and road traffic injuries. In the case of women the leading causes are diabetes, chronic kidney disease and ischemic heart diseases. The mental disorders and musculoskeletal conditions concentrate 18% of health lost. The risk factors that most affect men in Mexico are: alcohol consumption, overweight/obesity, high blood glucose levels and blood pressure and tobacco consumption (35.6 % of DALYs lost). In women, overweight and obesity, high blood sugar and blood pressure, lack of physical activity and consumption of alcohol are responsible for 40 % of DALYs lost. In both sexes the problems with diet contribute 12% of the burden. Conclusions. The epidemiological situation in Mexico, demands an urgent adaptation and modernization of the health system.


REFERENCES

  1. Lozano R, Soliz P, Gakidou E, Abbott-Klafter J, Feehan D, Vidal C, et al. Benchmarking performance of Mexican states using effective coverage. Lancet 2006; 368 (9548):1729-1741.

  2. Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global burden of disease and injury series, Vol. 1. Cambridge: Harvard University Press, 1996.

  3. Murray C. Quantifying the burden of disease: technical basis for disability- adjusted life years. Bull World Health Organ 1994;72(3):429-445.

  4. Murray C, Lopez AD. Global and regional cause of death patterns in 1990. Bull World Health Organ 1994;72(3):447-480.

  5. Murray C, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ 1994;72(3): 481-494.

  6. Murray C, Lopez AD, Jamison D. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994;72(3): 495-509.

  7. Salomon JA, Murray CJL. The Epidemiologic Transition Revisited: Compositional Models for Causes of Death by Age and Sex. Popul Dev Rev 2002; 28: 205-228.

  8. Lozano R, Murray CJL, Frenk J, Bobadilla JL. Burden of disease assessment and health system reform: Results of a study in Mexico. J Int Dev 1995;7:555-563.

  9. Gómez-Dantés H, Castro MV, Franco-Marina F, Bedregal P, Rodríguez- García J, Espinoza A, et al. La carga de la enfermedad en países de América Latina. Salud Publica Mex 2011;53 supl 2:S72-S77.

  10. República de Colombia. Ministerio de Salud. La Carga de la Enfermedad en Colombia. Bogotá, Colombia: Ministerio de Salud, 1994.

  11. Concha-Barrientos M, Aguilera-Sanhueza XP, Salas-Vergara J. Estudio de Carga de Enfermedad Informe final. Estudio Prioridades de Inversión en Salud. República de Chile: Ministerio de Salud, 1996.

  12. Lozano R. El peso de la enfermedad en México, avances y desafíos. En: Frenk J. Observatorio de la salud. Necesidades, servicios y políticas. México: Fundación Mexicana para la Salud, 1994: 23-61.

  13. Ministerio de Salud. Informe Final. Estudio de carga de enfermedad y Carga Atribuible. Chile: Ministerio de Salud, 2007.

  14. Escobar ML, Gallardo HM, Giraldo GP, Londoño JL, Rodríguez J. La Carga de la Enfermedad en Colombia. Santa Fé: Ministerio de Salud de Bogotá, 1994.

  15. Rodríguez J, Gallardo H. Carga Global de Enfermedad. Colombia 1985-1995. Ministerio de Salud. República de Colombia: Ministerio de Salud, 2000.

  16. Jourdan AM, da Costa LI, Gonçalves VJ, Mendes A, Schramm J, Crisostomo PJ, et al. Estudio de Carga Global de Enfermedades en Brasil 1998. Fundación Oswaldo Cruz. Brasil: Escuela Nacional de Salud Pública, 1998.

  17. Ministerio de Salud de Costa Rica. Medición de la carga de enfermedad en Costa Rica, año 2005. En: Programa Desarrollo del Sector Salud. Componente Fortalecimiento Institucional del Ministerio de Salud. Costa Rica: Ministerio de Salud de Costa Rica, 2008.

  18. Séuc A, Domínguez E. Acerca del cálculo de la carga de las enfermedades por morbilidad. Rev Cubana Hig Epidemiol 2005; 43(3).

  19. Lozada DP, Aguinaga PL, Paez LR, Olmedo TC, Pozo AA. El peso de la enfermedad en el Ecuador. Centro de Estudios de Población y Desarrollo Social. Texas: Universidad de Texas, 1999;8:141.

  20. Velásquez VA. Análisis del Estudio de Carga de Enfermedad en el Perú-MINSA 2004; Propuesta Metodológica para el Ajuste con Datos Nacionales de Morbilidad. Lima: Abt Associates Inc., 2006:64.

  21. Rodríguez-Abrego G, Zurita-Garza B, Ramírez-Martínez TJ. Muerte Prematura y discapacidad en los derechohabientes del Instituto Mexicano del Seguro Social. Salud Publica Mex 2007;49(2): 134-145.

  22. Ruiz F, Rodríguez J, Peñalosa E, Acosta N, O’Meara G. Años de vida saludable perdidos por discapacidad y muerte prematura (Avisas) para 129 causas. Nacional y por delegación, edad y sexo. Estudio realizado por el Centro de Proyectos para el Desarrollo (CENDEX) de la Universidad Javeriana para el Instituto Mexicano del Seguro Social (IMSS). Sitio en Internet, 2002. [Consultado en mayo de 2009]. Disponible en: http://www. cendex.org.co/pdf/981E-02.pdf

  23. Rodríguez-García J, Ruíz-Gómez F, Peñaloza-Quintero E. Carga de la Enfermedad en afiliados al Instituto Mexicano del Seguro Social (IMSS): asociación con indicadores socioeconómicos. México 2000. Rev Gerenc Polit Salud Bogotá (Colombia) 2009: 8(17): 123-139.

  24. Rodríguez-Abrego G, Escobedo-de la Peña J, Zurita GB, Ramírez T. Esperanza de vida saludable en la población mexicana con seguridad social. Perinatol Reprod Hum 2006:20(1-3).

  25. Murray CJL, Richards M, Newton J, Fenton KA, Atkinson C, Bennet D, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013, 381:997-1020

  26. US Burden of Disease Collaborators. The state of US health, 1990- 2010: burden of diseases, injuries, and risk factors [published online July 10, 2013]. JAMA. DOI: 10.1001/jama.2013.13805.

  27. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2013; 381:1987-2015.

  28. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman A, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2197-2223.

  29. Banco Mundial. Informe sobre el desarrollo Mundial 1993. Invertir en Salud. Washington DC: Oxford University Press, 1993.

  30. Murray C, Salomon J, Mathers C, Lopez A. Summary Measures of Population Health. Concepts, Ethics, measurement and applications. Geneva: WHO, 2002.

  31. Murray C, Lopez A, Mathers C, Stein C. The Global Burden of Disease 2000 project: aims, methods and data sources.Global Programme on Evidence for Health Policy Discussion Paper No. 36. Geneva: World Health Organization, November 2001 (revised).

  32. Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet 2012; 380(9859):2063-2066.

  33. Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 2012; 380(9859):2055-2058.

  34. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010. A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.

  35. Wang H, Dwyer L, Lofgren K, Rajaratnam J, Marcus J, Levin-Rector A, et al. Age specific and sex specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2071-2094.

  36. Instituto Nacional de Estadística y Geografía. Estadísticas de Mortalidad 1990-2011. [Consultado: febrero de 2012] Disponible en: http://www. inegi.org.mx/sistemas/olap/Proyectos/bd/continuas/mortalidad/Mortalidad- General.asp?s=est&c=11144&proy=mortgral_mg

  37. Instituto Nacional de Estadística y Geografía. Censos de Población y vivienda 1980-2010. [Consultado: febrero de 2012] Disponible en: http:// www.inegi.org.mx/est/contenidos/Proyectos/ccpv/default.aspx

  38. Instituto Nacional de Estadística y Geografía. Encuesta Nacional de la Dinámica Demográfica 1992. [Consultado: 10 de marzo de 2012] Disponible en: http://www.inegi.org.mx/est/contenidos/Proyectos/Encuestas/ Hogares/especiales/enadid/enadid1992/default.aspx

  39. Dirección General de Estadística. Encuesta Mexicana de Fecundidad 1976-1977, México. [Consultado: 10 de marzo de 2012] Disponible en: http://opr.princeton.edu/archive/wfs/MX.aspx

  40. Integrated Public Use Microdata Series, International, IPUMS, Minnesota Population Center, University of Minnesota, EUA. [Consultado: febrero de 2012] Disponible en: https://international.ipums.org/international/

  41. SINAIS. Egresos hospitalarios por morbilidad en instituciones públicas del sector salud. México: Secretaría de Salud. [Consultado: febrero de 2012] Disponible en: http://sinais.salud.gob.mx/basesdedatos/eh_sectorial_ morbi.html

  42. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2008 revision. New York: United Nations, 2009.

  43. Naghavi M, Makela S, Foreman K, O´Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes of death data. Popul Health Metr 2010;8:9.

  44. Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr 2011; 9: 8.

  45. Foreman K, Lozano R, Lopez AD, Murray C. Modeling causes of death. An integrated approach using CODEm. Popul Health Metr 2012,10:1

  46. Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012; 379:413-431.

  47. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, et al. Breast and Cervical cancer in 187 countries between 1890 and 2010: a systematic analysis. Lancet 2011; 378:1461-1484.

  48. Instituto Nacional de Estadística y Geografía. Registros Administrativos/ Mortalidad. [Consultado: 10 de marzo de 2012] Disponible en: http:// www.inegi.org.mx/sistemas/olap/proyectos/bd/consulta.asp?p=mortgral&c =33465&s=est&cl=4

  49. Secretaría de Salud, DGIS. Bases de datos (Cubos): SINAIS, Salud, México. [Consultado: 10 de marzo de 2012] Disponible en: http://dgis. salud.gob.mx/cubos/

  50. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2129-2143. doi:10.1016/S0140-6736- (12)61680-8.

  51. Vos T, Flaxman A, Naghavi M, Lozano R, Michaud K, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global burden of Disease Study 2010. Lancet 2012; 380:2163-2196.

  52. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012; 380: 2144-2162.

  53. Secretaría de Salud, DGIS. Bases de datos (Cubos de egresos hospitalarios): SINAIS, Salud, México. [Consultado: febrero de 2012] Disponible en: http://pda.salud.gob.mx/cubos/cegresosxp.html

  54. Instituto Nacional de Salud Pública. Encuestoteca [sitio de internet]. [Consultado: febrero de 2012] Disponible en: http://www.insp.mx/encuestoteca. html

  55. Secretaría de Salud, DGE. Anuarios de morbilidad 1984-2011. [Consultado: marzo de 2010] Disponible en: http://www.epidemiologia.salud.gob. mx/anuario/html/anuarios.html

  56. Mathers CD, Salomon JA, Ezzati M, Begg S, Hoorn SV, Lopez AD. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. En: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, eds. Global Burden of Disease and Risk Factors. Washington, DC: World Bank, 2006.

  57. Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.

  58. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2010 revision. New York: United Nations, 2011.

  59. Institute of Health Metrics and Evaluation. Global Burden of Disease [sitio de internet]. [Consultado: agosto-septiembre de 2013] Disponible en: http://www.healthmetricsandevaluation.org/gbd

  60. Instituto Nacional de Estadística y Geografía. Estadísticas Históricas de México, Tomo I. México 2000. [Consultado: marzo de 2010] Disponible en: http://www.inegi.org.mx/prod_serv/contenidos/espanol/bvinegi/productos/ integracion/pais/historicas/ehmii1.pdf

  61. Mathers C, Ma Fat D, Inoue M, Rao Ch, Lopez A. Counting the death and what they died from: an assessment of the global status of causes of dearh data. Bull World Health Organ 2005; 83: 17-177.

  62. Levey A, Jong P, Coresh J, El Nahas M, Astor B, Matsushita K, et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011;80:17-28. doi:10.1038/ ki.2010.483

  63. Li SQ, Cunningham J, Cass A. Renal-related deaths in Australia 1997- 1999. Intern Med J 2004; 34: 259-265

  64. Levey A, Caresh J. Chronic Kidney Disease. Lancet 2012; 379:165-180.

  65. Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labeling many people as diseased. BMJ 2013; 347:f4298

  66. Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J 1993;69:204-210.

  67. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 2004;27:694-698.

  68. Schernthaner G, Schernthaner GH. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk. J Nephrol 2013; 14:0. doi: 10.5301/jn.5000281.

  69. Correa-Rotter R, Cusumano AM. Present, prevention, and management of chronic kidney disease in Latin America. Blood Purif 2008; 26 (1): 90-94.

  70. Zakkerkish M, Shahbazian HB, Latifi SM, Moravej-Aleali A. Albuminuria and its correlates in type 2 diabetic patients. Iran J Kidney Dis 2013;7:268-276.

  71. Friedman AN, Chambers M, Kamendulis LM, Temmerman J. Shortterm changes after a weight reduction intervention in advanced diabetic nephropathy. Clin J Am Soc Nephrol 2013 [Publicado en línea. Consultado el 10 de octubre de 2013]. doi:10.2215/CJN.04010413.

  72. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762.

  73. Uusitupa M, Siitonen O, Penttilä I, Aro A, Pyörälä K. Proteinuria in Newly Diagnosed Type II Diabetic Patients. Diabetes Care 1987; 10:191-194.

  74. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJL, De Zeeuw D, De Jong PE, The PREVEND Study Group. An elevated albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int 2004; 66:s18-s21.

  75. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, for the UKPDS Group. Development and progression of nephropathy in type 2 diabetes. The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225-232.

  76. Parving H, Gall MA, Skøtt P, Jørgensen H, Løkkegaard H, Jørgensen F, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:758-762.

  77. Bakris GL, Williams M, Dworkin L, Elliot WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36:646-661.

  78. Fernandez C. Renal replacement therapy in Latin America. Kidney Int 2000; 57 Suppl. 74:S55-S70.

  79. Santiago-Delpin EA, Garcia VD. Latin American transplant registry viiith report: 1998. Transplant Proc 1999; 31(1-2): 214-216.

  80. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366(9500): 1875-1881.

  81. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315-335.

  82. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2010 Revision, Vol 1 and 2: Comprehensive Tables. New York: United Nations, 2011. [Consultado: marzo de 2010] Disponible en: http://www.countdown2015mnch.org/ documents/2013Report/Countdown_2013-Update_withprofiles.pdf

  83. Lozano R, Gómez-Dantés H, Castro MV, Franco-Marina F, Santos Preciado JI. Avances en los Objetivos de Desarrollo del Milenio 4 y 5 en Mesoamérica. Salud Publica Mex 2011;53 supl 3:S295-S302.

  84. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza- Aguilar M, Johnson B, Gomez-Altamirano C, et al. Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico. N Engl J Med 2010;362:299-305.

  85. Lazcano-Ponce E, Schiavon R, Uribe-Zuñiga P, Walker D, Suarez-Lopez L, Luna-Gordillo R, et al. Cobertura de atención del parto en México. Su interpretación en el contexto de la mortalidad materna. Salud Publica Mex 2013; 55 suppl 2: S214-S224.

  86. Bennett K, Cardiel MH, Ferraz MB, Riedemann P, Goldsmith CH, Tugwell P. Community screening for Rheumatic Disorder: Cross Cultural adaptation and Screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. J Rheumatol 1997;24:160-168.

  87. Estrada-Castañón R, Torres-Bibiano B, Alarcón-Hernández H, Villegas- Arrizón A, Martínez-Sandoval E, Chávez-López G, Andersson N. Epidemiología cutánea en dos sectores de atención médica en Guerrero, Mexico. Derm Rev Mex 1992, 36: 29-34.

  88. Hay RJ, Estrada-Castanon R, Alarcon-Hernandez H, Chavez-Lopez G, Lopez-Fuentes LF, Paredes-Solis S, Andersson N. Wastage of family income on skin disease in Mexico. BMJ 1994; 309: 848.

  89. Williams H. Is Eczema really on the increase worldwide? Am Acad All Asthma Immunol 2008, 121:947-1000.

  90. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W. The epidemiology of major depressive episodes: Results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003;12(1):3-21.

  91. Slone LB, Norris FH, Murhpy AD, Baker CK, Perilla JL, Diaz K, et al. Epidemiology of major depression in four cities in Mexico. Depress Anxiety 2006; 23:158-167.

  92. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl R, Kessler RC, Demler O, et al. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Org 2000; 78(4):413-426.

  93. Benjet C, Borges G, Medina-Mora ME, Zambrano J, Aguilar-Gaxiola S. Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey. J Child Psychol Psychiatry 2009;50(4):386-395.

  94. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C, et al. Prevalence, service, use and demographic correlates of 12-month DSM IV psychiatric disorders in Mexico: Results from the Mexican National Comorbidity Survey. Psychol Med 2005;35(12):1773-1783.

  95. Lozano-Ascencio R, Gómez-Dantés H, Zitko P, Franco F. Capítulo 4. El caso de la depresión en el manejo de la depresión y la esquizofrenia en México. Un estudio de costo efectividad. En: Medina-Mora ME, Robles R (eds.). La carga de enfermedad mental en México. México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, 2009.

  96. Lozano-Ascencio R, Zitko P, Gómez-Dantés H. La carga atribuible al consumo de alcohol. En: Medina-Mora ME, Robles R, Cortina D, Real T (eds). Evaluación de políticas públicas para el control del abuso de alcohol en México. México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, 2009.

  97. Hernández B, Cuevas-Nasau L, Shamah-Levy T, Monterrubio E, Ramírez-Silva CI, García-Feregrino B, et al. Factores asociados con sobrepeso y obesidad en niños mexicanos de edad escolar: resultados de la Encuesta Nacional de Nutrición 1999. Salud Publica Mex 2003;45 Suppl 4:S551-S557.

  98. Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, González-de Cossío T, Hernández-Prado B, Sepúlveda J. Encuesta Nacional de Nutrición 1999. Estado nutricio de niños y mujeres en México. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2001.

  99. Shamah-Levy T, Villalpando-Hernández S, Rivera-Dommarco JA. Resultados de Nutrición de la ENSANUT 2006. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2007.

  100. Bonvecchio A, Safdie M, Monterrubio E, Gust T, Villalpando S, Rivera J. Overweight and obesity trends in Mexican children 2 to 18 years of age from 1988 to 2006. Salud Publica Mex 2009; 51(sup 4):586-594.

  101. Cuevas-Nasu L, Hernández-Prado B, Shamah-Levy T, Monterrubio EA, Morales-Ruan MC, Moreno-Macías LB. Overweight and obesity in school children aged 5 to 11 years participating in food assistance programs in Mexico. Salud Publica Mex 2009;51 suppl 4:S630-S637.




2020     |     www.medigraphic.com